FDA
approval
· 2018-05-24
FDA Approved: PALYNZIQ — Original Application (BioMarin Pharmaceutical Inc.)
Summary
FDA approved PALYNZIQ (pegvaliase-pqpz) from BioMarin Pharmaceutical for the treatment of adults with phenylketonuria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PALYNZIQ (PEGVALIASE-PQPZ)